Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Population awareness of risks related to medicinal product use in Vientiane Capital, Lao PDR: a cross-sectional study for public health improvement in low and middle income countries

Authors: Céline Caillet, Chanvilay Sichanh, Lamphone Syhakhang, Cyrille Delpierre, Chanthanom Manithip, Mayfong Mayxay, Maryse Lapeyre-Mestre, Paul N Newton, Anne Roussin

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

While essential medicines have been made more available in all but the most remote areas in low and middle income countries (L/MICs) over the past years, inappropriate and incorrect use of good quality medicines remains a key impediment for public health. In addition, as medicines have a potential to cause harm (medicine risks), adequate awareness by medicine users of the risks of adverse reactions is essential, especially as self-medication is common in L/MICs. This study aimed to investigate the awareness of Lao residents regarding medicine risks in Vientiane Capital, Lao People’s Democratic Republic.

Methods

Face-to-face interviews using structured questionnaires of 144 residents older than 16 years were carried out in 12 randomly selected villages out of the 146 villages of Vientiane Capital with at least one health facility.

Results

The respondents were mainly (85.0 %) the heads of households or their husband/spouse . The majority of the respondents were unaware (61.8 %) of medicine risks. Compared to residents living in the urban district of Xaysetha, living in peri-urban and even more in rural areas were identified as factors associated with being unaware of medicine risks [adjusted odds ratio (aOR) =3.3, 95 % Confidence Interval (CI) = 1.1–9.4]) and aOR =7.5 (95 % CI = 2.3–24.2), respectively]. In addition, more than half of the respondents had never heard of poor quality medicines, with a higher rate in rural/peri-urban compared to urban districts (55.6 % vs 38.9 %, respectively, p = 0.02). Finally, approximately one third of all respondents thought that traditional medicines could not cause harm.

Conclusions

Overall, these results suggest a lack of awareness about medicinal product risks. Differences according to the place of residence are apparent and could be partly explained by a lower level of training of healthcare providers in contact with the population in the rural districts in particular. Communication on medicinal product risks to patients through well-trained healthcare providers could probably make a valuable contribution towards the appropriate use of medicines in L/MICs.
Literature
1.
Peters DH, Bloom G. Developing world: bring order to unregulated health markets. Nature. 2012;487:163–5.CrossRefPubMed
2.
3.
Shankar PR, Partha P, Shenoy N. Self-medication and non-doctor prescription practices in Pokhara valley, Western Nepal: a questionnaire-based study. BMC Fam Pract. 2002;3:17.CrossRefPubMedPubMedCentral
4.
Ernst E, Pittler MH. Risks associated with herbal medicinal products. Wien Med Wochenschr 1946. 2002;152:183–9.CrossRef
5.
Ernst E. Herbal medicines: balancing benefits and risks. Novartis Found Symp. 2007;282:154–67. discussion 167–172, 212–218.CrossRefPubMed
6.
Newton PN, Fernández FM, Plançon A, Mildenhall DC, Green MD, Ziyong L, et al. A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia. PLoS Med. 2008;5:e32.CrossRefPubMedPubMedCentral
7.
8.
Paphassarang C, Tomson G, Choprapawon C, Weerasuriya K. The Lao national drug policy: lessons along the journey. Lancet. 1995;345:433–5.CrossRefPubMed
9.
Stenson B, Syhakhang L, Eriksson B, Tomson G. Real world pharmacy: assessing the quality of private pharmacy practice in the Lao People’s Democratic Republic. Soc Sci Med. 2001;52:393–404.CrossRefPubMed
10.
Sihavong A, Lundborg CS, Syhakhang L, Akkhavong K, Tomson G, Wahlström R. Antimicrobial self medication for reproductive tract infections in two provinces in Lao People’s Democratic Republic. Sex Transm Infect. 2006;82:182–6.CrossRefPubMedPubMedCentral
11.
12.
Keohavong B, Syhakhang L, Sengaloundeth S, Nishimura A, Ito K. Rational use of drugs: prescribing and dispensing practices at public health facilities in Lao PDR. Pharmacoepidemiol Drug Saf. 2006;15:344–7.CrossRefPubMed
13.
Sengaloundeth S, Green MD, Fernández FM, Manolin O, Phommavong K, Insixiengmay V, et al. A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR - implications for therapeutic failure and drug resistance. Malar J. 2009;8:172.CrossRefPubMedPubMedCentral
14.
15.
Mobillion V, Peyronnie K, Vallée J. L’offre de soins à Vientiane (RDP Lao): entre contrôle territorial et économie marchande. Space Popul Soc. 2006;2–3:341–9.
16.
Syhakhang L, Freudenthal S, Tomson G, Wahlström R. Knowledge and perceptions of drug quality among drug sellers and consumers in Lao PDR. Health Policy Plan. 2004;19:391–401.CrossRefPubMed
17.
Levy PS, Lemeshow S. Systematic sampling. In: John Wiley and Sons, editor. Sampling of populations, methods and applications. 3rd ed. 1999.
18.
19.
Alvesson HM, Lindelow M, Khanthaphat B, Laflamme L. Coping with uncertainty during healthcare-seeking in Lao PDR. BMC Int Health Hum Rights. 2013;13:28.CrossRefPubMedPubMedCentral
20.
Alvesson HM, Lindelow M, Khanthaphat B, Laflamme L. Shaping healthcare-seeking processes during fatal illness in resource-poor settings. A study in Lao PDR. BMC Health Serv Res. 2012;12:477.CrossRefPubMedPubMedCentral
21.
Richards E, Theobald S, George A, Kim JC, Rudert C, Jehan K, et al. Going beyond the surface: gendered intra-household bargaining as a social determinant of child health and nutrition in low and middle income countries. Soc Sci Med. 2013;95:24–33.CrossRefPubMed
22.
23.
24.
25.
Vidanapathirana J, Abramson MJ, Forbes A, Fairley C. Mass media interventions for promoting HIV testing. In: The Cochrane Collaboration, editor. Cochrane database of systematic reviews. Chichester: John Wiley & Sons, Ltd; 2005.
26.
Naugle DA, Hornik RC. Systematic review of the effectiveness of mass media interventions for child survival in low- and middle-income countries. J Health Commun. 2014;19 Suppl 1:190–215.CrossRefPubMedPubMedCentral
27.
Syhakhang L, Lundborg CS, Lindgren B, Tomson G. The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999. Pharm World Sci PWS. 2004;26:333–8.CrossRefPubMed
28.
29.
Syhakhang L. The quality of private pharmacy services in a Province of Lao PDR : perceptions, practices and regulatory enforcements. PhD thesis, Division of International Health (IHCAR), Department of Public Health Sciences. Stockholm: Karolinska Institutet; 2002.
30.
Brounéus F, Macleod G, Maclennan K, Parkin L, Paul C. Drug safety awareness in New Zealand: public knowledge and preferred sources for information. J Prim Health Care. 2012;4:288–93.PubMed
31.
Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff Proj Hope. 2007;26:731–40.CrossRef
32.
Dowse R, Barford K, Browne SH. Simple, illustrated medicines information improves ARV knowledge and patient self-efficacy in limited literacy South African HIV patients. AIDS Care. 2014;26:1400–6.CrossRefPubMedPubMedCentral
33.
Minimum information for sensible use of self-prescribed medicines. An international consensus. Lancet. 1977;2:1017–19.
34.
Lal A, Sethi A, Ray A. Informing patients about drugs. Natl Med J India. 1995;8:36–8.PubMed
35.
Morris LA, Halperin JA. Effects of written drug information on patient knowledge and compliance: a literature review. Am J Public Health. 1979;69:47–52.CrossRefPubMedPubMedCentral
36.
Russell S. Treatment-seeking behaviour in urban Sri Lanka: trusting the state, trusting private providers. Soc Sci Med 1982. 2005;61:1396–407.
37.
Riewpaiboon W, Chuengsatiansup K, Gilson L, Tangcharoensathien V. Private obstetric practice in a public hospital: mythical trust in obstetric care. Soc Sci Med. 2005;61:1408–17.CrossRefPubMed
38.
Gilson L. Editorial: building trust and value in health systems in low- and middle-income countries. Soc Sci Med. 2005;61:1381–4.CrossRefPubMed
39.
40.
Entezari-Maleki T, Taraz M, Javadi MR, Hajimiri MH, Eslami K, Karimzadeh I, et al. A two-year utilization of the pharmacist-operated drug information center in Iran. J Res Pharm Pract. 2014;3:117–22.CrossRefPubMedPubMedCentral
41.
Melnyk PS, Shevchuk YM, Remillard AJ. Impact of the dial access drug information service on patient outcome. Ann Pharmacother. 2000;34:585–92.CrossRefPubMed
42.
Dodoo A, Hugman B. Risk perception and communication in sub-Saharan Africa. Drug Saf Int J Med Toxicol Drug Exp. 2012;35:1041–52.CrossRef
43.
Hien LTT, Takano T, Seino K, Ohnishi M, Nakamura K. Effectiveness of a capacity-building program for community leaders in a healthy living environment: a randomized community-based intervention in rural Vietnam. Health Promot Int. 2008;23:354–64.CrossRef
44.
Koenig SP, Léandre F, Farmer PE. Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience. AIDS Lond Engl. 2004;18 Suppl 3:S21–5.CrossRef
45.
Kaewkungwal J, Apidechkul T, Jandee K, Khamsiriwatchara A, Lawpoolsri S, Sawang S, et al. Application of mobile technology for improving expanded program on immunization among highland minority and stateless populations in Northern Thailand border. JMIR MHealth UHealth. 2015;3:e4.CrossRefPubMedPubMedCentral
46.
Baron S, Goutard F, Nguon K, Tarantola A. Use of a text message-based pharmacovigilance tool in Cambodia: pilot study. J Med Internet Res. 2013;15:e68.CrossRefPubMedPubMedCentral
Metadata
Title
Population awareness of risks related to medicinal product use in Vientiane Capital, Lao PDR: a cross-sectional study for public health improvement in low and middle income countries
Authors
Céline Caillet
Chanvilay Sichanh
Lamphone Syhakhang
Cyrille Delpierre
Chanthanom Manithip
Mayfong Mayxay
Maryse Lapeyre-Mestre
Paul N Newton
Anne Roussin
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1948-2

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue

Study protocol

A cluster randomised controlled trial to investigate the effectiveness and cost effectiveness of the ‘Girls Active’ intervention: a study protocol

Study protocol

Cultural adaptation of a brief motivational intervention for heavy drinking among Hispanics in a medical setting

Research article

Evaluation of work-based screening for early signs of alcohol-related liver disease in hazardous and harmful drinkers: the PrevAIL study

Research article

Under consumers’ scrutiny - an investigation into consumers’ attitudes and concerns about nudging in the realm of health behavior

Research article

Built environment interventions aimed at improving physical activity levels in rural Ontario health units: a descriptive qualitative study

Research article

Acceptability of a theory-based sedentary behaviour reduction intervention for older adults (‘On Your Feet to Earn Your Seat’)